Leave Your Message
-
Phone
-
E-mail
-
Whatsapp
-
Wechat
The medical disposables industry has witnessed unprecedented growth in recent years, with PVC tablecloth film emerging as a critical component in healthcare applications. This versatile material offers exceptional barrier properties, chemical resistance, and cost-effectiveness, making it indispensable for medical packaging, protective equipment, and disposable medical devices.
PVC (Polyvinyl Chloride) film technology has evolved significantly to meet stringent medical-grade standards. Modern manufacturing processes ensure biocompatibility, sterilization compatibility, and compliance with international healthcare regulations including FDA, ISO 10993, and European Pharmacopoeia standards.
The global medical disposables market, valued at over $250 billion, continues to expand at a CAGR of 6.8%, driven by increasing healthcare expenditure, aging populations, and heightened awareness of infection control. PVC film products constitute a substantial segment of this market, serving critical applications in hospitals, clinics, and home healthcare settings.
Medical-grade PVC films are formulated to minimize cytotoxicity and ensure patient safety. Rigorous testing protocols verify compatibility with human tissue and blood contact applications.
Compatible with multiple sterilization methods including gamma radiation, ethylene oxide, and autoclave processes, maintaining structural integrity and barrier properties.
Excellent water vapor transmission resistance protects sensitive medical products from humidity, ensuring extended shelf life and product efficacy.
Superior resistance to pharmaceutical compounds, disinfectants, and bodily fluids ensures product integrity in demanding medical environments.
Crystal-clear formulations enable visual inspection of packaged medical devices and pharmaceuticals without compromising protection.
Full compliance with FDA 21 CFR, ISO 10993, USP Class VI, and EU Medical Device Regulations ensuring global market acceptance.
PVC tablecloth film has become the material of choice for medical disposables due to its unique combination of properties: exceptional clarity for product visibility, superior barrier protection against contaminants, compatibility with various sterilization methods, cost-effectiveness for single-use applications, and ease of processing for complex medical device designs. The material's versatility allows manufacturers to customize formulations for specific medical requirements, from flexible IV bags to rigid pharmaceutical packaging.
Sustainable Medical Plastics: The healthcare industry is increasingly focusing on environmentally responsible materials. Bio-based PVC alternatives and recycling programs for medical-grade plastics are gaining traction, with manufacturers developing closed-loop systems for non-contaminated medical packaging.
Smart Packaging Technologies: Integration of RFID tags, temperature indicators, and tamper-evident features into PVC medical packaging enables enhanced supply chain tracking, patient safety, and regulatory compliance. These intelligent packaging solutions are becoming standard in pharmaceutical and high-value medical device applications.
Advanced Barrier Coatings: Multilayer PVC films with specialized coatings provide enhanced protection against oxygen, moisture, and light-sensitive pharmaceutical compounds. These innovations extend product shelf life and enable room-temperature storage of previously refrigerated medications.
Heightened Safety Requirements: Global regulatory bodies continue to strengthen requirements for medical-grade materials. Recent updates to ISO 10993 biocompatibility standards and EU Medical Device Regulation (MDR) compliance necessitate comprehensive material characterization and extractables/leachables studies.
Pandemic-Driven Demand: COVID-19 dramatically accelerated demand for medical disposables, with PVC film consumption in healthcare applications increasing by over 40% during 2020-2021. This surge has prompted capacity expansions and technological investments throughout the supply chain.
Emerging Market Growth: Asia-Pacific regions, particularly China, India, and Southeast Asia, are experiencing rapid healthcare infrastructure development. This expansion drives substantial demand for cost-effective, high-quality medical disposables, with PVC film products playing a central role in meeting these needs.
Our medical-grade PVC film production facilities incorporate cutting-edge technology to ensure consistent quality and regulatory compliance. Cleanroom manufacturing environments meet ISO Class 7 and 8 standards, preventing particulate contamination during production.
Advanced calendering and extrusion lines enable precise thickness control from 0.05mm to 2.0mm, accommodating diverse medical application requirements. Real-time quality monitoring systems utilize spectroscopy and vision inspection to detect and eliminate defects before material leaves production.
Our CNAS-accredited laboratories conduct comprehensive testing including biocompatibility assessments, mechanical property analysis, barrier performance evaluation, and extractables/leachables profiling. This rigorous testing regime ensures every batch meets or exceeds international medical device standards.
Jiangsu Dahai Plastics Co., Ltd. has established itself as a premier manufacturer of medical-grade PVC films and specialty plastics. Founded in 1996, our company has grown from a regional supplier to an internationally recognized producer serving healthcare markets across South America, Southeast Asia, Africa, and beyond.
With over 20 advanced production lines and 450+ dedicated employees, including 30% technical and management professionals, we maintain annual production capacity exceeding 100,000 tons. Our 120,000+ square meter manufacturing campus incorporates the latest environmental protection systems and quality control technologies.
Our commitment to innovation drives continuous investment in research and development. Collaborative partnerships with leading universities enable us to stay at the forefront of medical materials technology, developing next-generation solutions for evolving healthcare challenges.
We possess laboratories accredited by China National Commission for Conformity Assessment (CNAS), equipped with world-class experimental equipment and physical-chemical testing instruments. Our comprehensive testing protocols include:
ISO 10993 compliant cytotoxicity, sensitization, and irritation testing ensures patient safety for all medical contact applications.
Tensile strength, elongation, tear resistance, and dimensional stability testing verify material performance specifications.
Extractables and leachables profiling, residual monomer analysis, and plasticizer migration studies ensure chemical safety.
All our medical-grade products meet rigorous international standards including EN-71, ASTM-F-963, CONEG, RoHS, FDA 21 CFR, and ISO certifications, ensuring global market acceptance and regulatory compliance.
Make green materials, create a good and healthy life!
To become the domestic polymer material application industry leader, to build a world-class brand!
Independent innovation intelligent future! Team style: people-oriented safety first!
Integrity, pragmatic, efficient, win-win!
Tongzhou Huaming Plastic Co., Ltd. was established, beginning our journey in specialty plastics manufacturing.
Tongzhou Huaming Plastics Co., Ltd. was transformed to Jiangsu Dahai Plastics Co., LTD., marking our expansion into medical-grade materials.
Nantong Runyang Plastic Co., Ltd. was established, expanding our production capacity and market reach.
Dahai Real Estate Development Co., Ltd. was established, diversifying our business portfolio.
Field E-commerce company was established, embracing digital transformation and global market access.
Jiangyin Zhonglian Real Estate company was established, further strengthening our corporate infrastructure.
Jiangyin Huayue Real Estate Development Co., Ltd. was established, continuing our strategic expansion.
Jiangsu Houbang Industrial Co., LTD. was founded, launching our intelligent manufacturing project for new medical materials.
